Sector
PharmaceuticalsOpen
₹100.95Prev. Close
₹100.95Turnover(Lac.)
₹2.12Day's High
₹100.95Day's Low
₹100.652 Week's High
₹193.552 Week's Low
₹81Book Value
₹19.62Face Value
₹10Mkt Cap (₹ Cr.)
115.6P/E
83.18EPS
1.21Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 11.49 | 11.49 | 11.63 | 8.5 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 9.67 | 7.87 | 1.12 | -3.79 |
Net Worth | 21.16 | 19.36 | 12.75 | 4.71 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Revenue | 2.37 | 7.67 | 5.8 | 5.27 |
yoy growth (%) | -69.1 | 32.33 | 9.92 | -26.96 |
Raw materials | -1.45 | -4.31 | -2.71 | -2.73 |
As % of sales | 61.45 | 56.13 | 46.85 | 51.85 |
Employee costs | -0.44 | -0.51 | -0.88 | -0.79 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Profit before tax | -1.25 | -0.47 | -2.47 | -0.96 |
Depreciation | -0.04 | -0.04 | -0.44 | -0.53 |
Tax paid | 0.12 | -1.53 | 0.07 | 0.29 |
Working capital | -1 | -2.28 | 3.43 | -4.45 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -69.1 | 32.33 | 9.92 | -26.96 |
Op profit growth | -183.21 | -148.27 | -277.68 | -252.99 |
EBIT growth | -146.73 | -175.52 | -426.79 | -207.7 |
Net profit growth | -43.51 | -16.46 | 259.74 | -34.27 |
Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|---|
Gross Sales | 187.74 | 188.71 | 167.61 | 163.03 | 89.52 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 187.74 | 188.71 | 167.61 | 163.03 | 89.52 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 1.68 | 0.82 | 0.77 | 0.33 | 0.21 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,647.35 | 92.29 | 3,95,254.45 | 2,000.46 | 0.97 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,493.2 | 78.03 | 1,72,374.06 | 667 | 0.46 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,483.15 | 24.33 | 1,19,795.19 | 1,485.4 | 1.08 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,326.4 | 20.69 | 1,10,689.83 | 1,200.7 | 0.6 | 5,546.3 | 345.79 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,167.95 | 56.27 | 1,07,213.01 | 474 | 1.01 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Non Executive Director
Ami M Shah
Independent Director
T V Anantharaman
Independent Director
Yogesh Varia
Independent Director
Harish S Panpalia
Director & Chief Executive Off
Mihir Prakash Shah
Managing Director & CFO
Binoy Baiju Shah
Gala 114 Bldg No 8,
Jogani Ind Complex Chunabhatti,
Maharashtra - 400022
Tel: 91-022-6825 2525
Website: http://www.naxparlab.com
Email: compliance@naxparlab.com
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: www.linkintime.co.in
Email: paytm.ipo@linkintime.co.in
Summary
Parnax Lab Limited (Formerly Known as Krishna Deep Trade & Investment Ltd ) was incorporated in August, 1982. The Company changed the name from Krishna Deep Trade & Investment Ltd to Parnax Lab Limite...
Read More
Reports by Parnax Lab Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.